Morning Overview on MSN
Ozempic just delivered big weight loss for adults over 65 in a new analysis — and tightened the heart and metabolic numbers doctors watch most closely
When researchers pooled data from six major semaglutide weight-loss trials and zeroed in on participants aged 65 and older, ...
For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight ...
Morning Overview on MSN
A lower-calorie Mediterranean diet paired with exercise just sharply cut type 2 diabetes risk in a major trial — even without big weight loss
A Mediterranean diet with moderate calorie cuts, combined with regular exercise, reduced the risk of developing type 2 ...
Losing weight is not just about counting calories and hitting the gym hard; it’s more about the mindset that brings results.
Lilly’s new obesity drug produced roughly 28% average weight loss in trials — big efficacy, real safety and access questions.
According to the Centers for Disease Control and Prevention, nearly half of adults worldwide have high blood pressure (that's ...
GLP‑1 and next‑generation obesity drugs are gaining traction across the U.S. and globally, which is good news for investors.
Low in carbs and calories and high in protein and/or fiber, these dinner recipes can help support your weight loss goals.
Eli Lilly’s huge 50-hectare manufacturing hub in Kinsale has placed Ireland at the centre of the biggest shift in global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results